Magrath George — SEC Form 4 filings
SEC reporting owner CIK 1999390. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-20 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 230,000 shares, $256,580 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 43,424 shares, $204,900 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 24,438 shares @ $5.21 ($127,327) in Opus Genetics, Inc., filed 2026-03-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | Chief Executive Officer, Director | 15 | 5 legs · 230,000 sh · $256,580 | 3 legs · 43,424 sh · $204,900 | 12 |
Form 4 filings — Magrath George
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Opus Genetics, Inc. (IRD) | Option exercise (M): 392,157 @ $1.15 · Tax withholding (F): 75,541 @ $5.97 · Option exercise (M): 392,157 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 9,475 @ $2.95 | EDGAR |
| 2026-04-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 9,511 @ $5.22 | EDGAR |
| 2026-03-18 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 24,438 @ $5.21 | EDGAR |
| 2026-01-26 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 483,639 @ $0 | EDGAR |
| 2025-11-05 | 4/A | Opus Genetics, Inc. (IRD) | Tax withholding (F): 30,350 @ $2.30 | EDGAR |
| 2025-11-04 | 4 | Opus Genetics, Inc. (IRD) | Tax withholding (F): 30,350 @ $2.30 | EDGAR |
| 2025-03-26 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 392,157 · Grant/award (A): 392,157 (derivative) | EDGAR |
| 2025-03-17 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 330,697 @ $0 · Grant/award (A): 330,697 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | Opus Genetics, Inc. (IRD) | Purchase (P): 100,000 @ $0.98 | EDGAR |
| 2024-12-23 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 6,200 @ $0 | EDGAR |
| 2024-11-19 | 4 | Opus Genetics, Inc. (IRD) | Purchase (P): 90,294 @ $1.01 · Purchase (P): 9,706 @ $1.02 | EDGAR |
| 2024-11-05 | 4 | Opus Genetics, Inc. (IRD) | Tax withholding (F): 37,050 @ $1.18 | EDGAR |
| 2024-05-21 | 4 | Ocuphire Pharma, Inc. (OCUP) | Purchase (P): 5,000 @ $1.75 | EDGAR |
| 2024-03-20 | 4 | Ocuphire Pharma, Inc. (OCUP) | Purchase (P): 25,000 @ $1.96 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1999390 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →